1991
Artículos
Andrés A, Vázquez S, Cebrián M.P. Los nefrólogos como responsables de la donación de órganos: Experiencia en el Hospital 12 de Octubre. Nefrologia. 1991;11(Suppl. 1):32-4
De la Serna FJ, Gilsanz F, Praga M, Estenoz J. Erythropoietin and improvement in the erythropoiesis of chronic hemodialysis patients treated with desferrioxamine. Clin Nephrol. 1991 Sep;36(3):157-8 [PubMed]
Hernandez E, Praga M, Moreno F, Montoyo C. Acute renal failure induced by oral acyclovir. Clin Nephrol. 1991 Sep;36(3):155-6 [PubMed]
Hollenberg NK, Rodicio JL. The kidney in hypertension: treatment strategies. J Cardiovasc Pharmacol. 1991;18 Suppl 4:S57-61 [PubMed]
Khayal, Tourkantonis, Knorr A, Erylmaz, Sherif, Rappelli, et al. New aspects of calcium antagonism in the treatment of hypertension – Proceedings of the Nitrendipine Symposium Held in Cairo, Egypt, September 27-30, 1990 – Panel discussion. J Cardiovasc Pharmacol. 1991;18:s22-5
Mancia G, Akgun, Mimran, Ruilope L, Tourkantonis, Palatini, et al. New aspects of calcium antagonism in the treatment of hypertension – Proceedings of the Nitrendipine Symposium Held in Cairo, Egypt, September 27-30, 1990 – Round-table discussion. J Cardiovasc Pharmacol. 1991;18:s26-31
Mancia G, London, Staessen, Ritz, Seedat, Rodicio JL, et al. Treatment of isolated systolic hypertension in the elderly – Discussion. J Cardiovasc Pharmacol. 1991;18:s41-4
Mazuecos A, Montoyo C, Andrés A, Campo C, Praga M. Absence of anaphylactoid reactions with the combined use of ACE inhibitors and AN69 hemodialysis membranes. Nephron. 1991;59(3):519 [PubMed]
Morales JM, Andrés A, Montoyo C, Ortuño B, Rodicio JL. Does calcium antagonist improve established early ciclosporin nephrotoxicity after renal transplantation? Nephron. 1991;57(2):227-9.
Morales JM, Campo C, Hernández E, Andrés A, Praga M, Montoyo C, et al. Influence of donor and recipient age on graft survival rate after renal transplantation with a protocol of low CyA doses. Transplant Proc. 1991;23(5):2622-3.
Praga M, Andrés A, Hernández E, Montoyo C, Mazuecos A, Campo C, et al. Tubular dysfunction in nephrotic syndrome: incidence and prognostic implications. Nephrol Dial Transplant. 1991;6(10):683-8.
Praga M, Borstein B, Andrés A, Arenas J, Oliet A, Montoyo C, et al. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis. 1991;17(3):330-8
Rodicio J. Dihydropyridines and their future in hypertension – Satellite Symposium to the 2nd International-Symposium on Calcium-Antagonists in Cardiovascular Care Basel, Switzerland, February 13, 1991 – Closing remarks. J Cardiovasc Pharmacol. 1991;18:s112-s112
Ruilope LM. Renal effects of nitrendipine. J Cardiovasc Pharmacol. 1991;18(Suppl 5):S10-3
Ruilope LM. Utilidad de los bloqueadores alfa postsinápticos en el tratamiento de la hipertensión arterial. Med Clin (Barc). 1991 Oct 19;97(13):495-6 [PubMed]
Ruilope LM, Guerrero L, Casal MC, Alcázar JM, Campo C, Mazuecos A, et al. Tolerance to nitrendipine in patients with arterial hypertension accompanying chronic renal failure. J Cardiovasc Pharmacol. 1991;18( Suppl 1):S71-3.
Villa E, Morales ME, Martinez J, De la Fuente A, Hurtado A, Santirso RA, et al. Acute effects of iloprost on blood pressure, heart rate, renal hemodynamics, diuresis, natriuresis, plasma renin activity and plasma norepinephrine in uninephrectomized hypertensive mongrel dogs. J Hypertens Suppl. 1991 Dec;9(6):S352-3 [PubMed]
Zaballos J, Pérez Cerda F, Riaño D, Dávila P, Martínez P, Sevillano A, et al. Anesthetic management of liver transplantation in a pregnant patient with fulminant hepatitis. Transplant Proc. 1991 Jun;23(3):1994-5 [PubMed]
.
1992
Artículos
Alcázar JM, Mazuecos A, García Hidalgo E, Lázaro T, Ruilope LM, Rodicio JL. Insuficiencia renal e hipertensión vasculorrenal. Nefrologia. 1992;12(Suppl. 5):99-106
Andrés A, Morales JM, Farias J, Hernández G, Gómez M, Calleja J, et al. Acute renal failure after liver transplantation in patients treated with cyclosporine. Transplant Proc. 1992;24(1):126-7
Borrego L, Gil R, Mazuecos A, Ruiz R, López JL, Iglesias L. Cholesterol embolism to the skin. Clin Exp Dermatol. 1992;17(6):424-6
Campo C, Ruilope LM. Efecto de la dieta sobre la progresión de la insuficiencia renal. Nefrología. 1992;12(Suppl. 5):66-76
Díez J, Ruilope LM, Rodicio JL. Abnormalities of renal function in essential hypertension with increased circulating levels of insulin-like growth factor I. Arch Mal Coeur Vaiss. 1992 Aug;85(8):1189-91 [PubMed]
García Cantón C, Morales JM, Fernández Zataraín G, Andrés A, Sánchez R, Hernández G, et al. Importancia clínica del fracaso renal agudo en pacientes con trasplante hepático tratados con ciclosporina A. Nefrologia. 1992;12(Suppl. 4):223-8
Montoyo C, Martínez MA, Campo C, Mazuecos A, Andrés A, Praga M. Nephrotic syndrome and focal glomerulosclerosis in adult polycystic kidney disease. Nephron. 1992;61(1):106-10
Morales JM, Aguado JM, Díaz González R, Salto E, Andrés A, Campo C, et al. Alkaline-encrusted pyelitis/cystitis and urinary tract infection due to corynebacterium urealyticum: a new severe complication after renal transplantation. Transplant Proc. 1992;24(1):81-2
Morales JM, Andrés A, Montoyo C, Praga M, Alcázar JM, Algranati L, et al. Effect of captopril, an angiotensin converting enzyme inhibitor, on the massive proteinuria due to chronic rejection after renal transplantation—a prospective study. Transplant Proc. 1992;24(1):92-3
Morales JM, Andrés A, Montoyo C, Praga M, Hernández E, Alcázar J.M, et al. Efecto del captopril, un inhibidor de la enzima de conversión de la angiotensina en la proteinuria nefrótica del rechazo crónico del trasplante Renal. Un estudio prospectivo. Nefrologia. 1992;12(Suppl. 5):130-3
Morales JM, Andrés A, Rodríguez Paternina E, Alcázar JM, Montoyo C, Rodicio JL. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study. Transplant Proc. 1992;24(1):89-91 [PubMed]
Morales M, Campo C, Castellano G, Colina F, Andrés A, Fuertes A, et al. Clinical implications of the presence of antibodies to hepatitis C after renal transplantation. Transplant Proc. 1992;24(1):78-80
Morales JM, Praga M, Andrés A, Ortuño B, Rodicio JL. Fracaso renal agudo por ciclosporina A. Posible papel patogénico de las prostaglandinas. Nefrologia. 1992;12(Suppl. 4):205-9
Morales JM, Sancho S, Muñoz Cepeda MA, Andrés A, Campo C, Alcázar JM, et al. CyA monotherapy in patients over 50 years of age after renal transplantation: short-term results. Transplant Proc. 1992;24(1):37-8
Praga M. Fracaso renal agudo en las enfermedades glomerulares primitivas. Nefrologia. 1992;12(Suppl. 4):147-152
Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis. 1992;20(3):240-8
Praga M, Hernández E, Rodicio JL. Efecto antiproteinúrico de los IECA. Influencia sobre la progresión de la Insuficiencia renal. Nefrologia. 1992;12(Suppl. 5):77-86
Prieto C, Pulido F, Rodríguez Paternina E, Algranati C, Bello I, Farias J, et al. Late acute rejection in renal transplant recipients: response to steroid treatment. Transplant Proc. 1992;24(1):35-6
Rodicio JL. New Aspects of Pathophysiology and Management of Hypertension – Proceedings of an Official Satellite Symposium Presented at the 1992 Meeting of the International-Society-of-Hypertension – Madrid, Spain, 14 June, 1992 – Preface. J Hum Hypertens. 1992;6:S1
Rodicio JL, Alcázar JM, Ruilope LM. The antihypertensive effect of verapamil in patients with chronic renal failure. J Hum Hypertens. 1992;6 Suppl 2:S41-3
Rodríguez Antolín A, Morales JM, Andrés A, Fernández Aparicio T, Díaz González R, Pamplona M, et al. Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs. Transplant Proc. 1992;24(1):105-6
Ruilope LM, Alcázar JM, Rodicio JL. Renal consequences of arterial hypertension. J Hypertens Suppl. 1992;10(7):S85-90
Ruilope LM, Casal MC, Guerrero L, Alcázar JM, Fernández ML, Lahera V, Et al. Sodium intake does not influence the effect of verapamil in hypertensive patients with mild renal insufficiency. Drugs. 1992;44 Suppl 1:94-8
Ruilope LM, Casal MC, Praga M, Alcázar JM, Decap G, Lahera V, Rodicio JL. Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake. J Am Soc Nephrol. 1992;3(6):1307-11
Sánchez R, Alcázar JM, Mazuecos A, Campos C, Mosquera J.R, Praga M, et al. Tratamiento del fracaso renal agudo en pacientes con fallo multiorgánico mediante hemodiálisis continua. Nefrologia. 1992;12(Suppl. 4):301-5
.
1993
Artículos
Aguado JM, Hidalgo M, Moya I, Alcázar JM, Jiménez MJ, Noriega AR. Ventricular arrhythmias with conventional and liposomal amphotericin. Lancet. 1993 Nov 13;342(8881):1239 [PubMed]
Aguado JM, Morales JM. The pathogenesis and treatment of kidney stones. N Engl J Med. 1993 Feb 11;328(6):444 [PubMed]
Aguado JM, Morales JM, Salto E, Lumbreras C, Lizasoaín M, Díaz-González R, et al. Encrusted pyelitis and cystitis by Corynebacterium urealyticum (CDC group D2): a new and threatening complication following renal transplant. Transplantation. 1993 Sep;56(3):617-22
Aguado JM, Salto E, Morales JM, Muñoz MA, Lizasoaín M, Lumbreras C, et al. Corynebacterium urealyticum: a new and threatening pathogen for the renal transplant patient. Transplant Proc. 1993;25(1 Pt 2):1493-4
Andrés Belmonte A. Selection of suboptimal donors. Transplantology. 1993;4(4):97-102
Andrés A, Morales JM, Lloveras J. Reuse of a transplanted kidney. N Engl J Med. 1993 Jun 3;328(22):1644 [PubMed]
Araque A, Mazuecos A, Andrés A, Sánchez R, Ortuño T, Praga M. Tratamiento con esteroides y clorambucil de las glomerulonefritis membranosas idiopáticas con insuficiencia renal progresiva. Nefrologia. 1993;13(4):350-5
Fernández Pinilla C, Luque Otero M, Martell Claros N, Alcázar de la Osa JM, Rodicio Díaz JL, Ruilope Urioste LM. Tratamiento de la hipertensión arterial esencial con hipercolesterolemia. Efectos de un bloqueador alfaadrenérgico y un inhibidor de la enzima conversiva de la angiotensina. Med Clin (Barc). 1993;101(5):168-71 [PubMed]
Hernández E, Praga M, Alcázar JM, Morales JM, Montejo JC, Jiménez MJ, Et al. Hemodialysis for treatment of accidental hypothermia. Nephron. 1993;63(2):214-6
Lahera V, Navarro J, Biondi ML, Ruilope LM, Romero JC. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am J Physiol. 1993 Feb;264(2 Pt 2):F344-7 [PubMed]
Mazuecos AM, Praga M, Araque A, Hernández E, Sánchez R, Andrés A, et al. Evolución a largo plazo de las glomerulonefritis membranosas idiopáticas no tratadas. Nefrologia. 1993;13(4):299-305
Mazuecos A, Ramos Guillén PC, Campo C, Sánchez R, Martínez MA, Praga M. Chronic renal insufficiency after an episode of macroscopic hematuria in IgA nephropathy. Nephron. 1993;64(3):452-5
Morales JM, Andrés A, Rodicio JL. Beneficial effects of calcium antagonists on cyclosporin nephrotoxicity after clinical renal transplantation. Nephrol Dial Transplant. 1993;8(9):880 [PubMed]
Morales JM, Muñoz MA, Castellano G, Colina F, Fuertes A, Andrés A, et al. Impact of hepatitis C in long-functioning renal transplants: a clinicopathological follow-up. Transplant Proc. 1993;25(1 Pt 2):1450-3
Morales Cerdán JM, Castellano G, Colina F, Andrés A, Muñoz MA, Hernández E, et al. Evolución clínico-patológica de la hepatitis c tras el trasplante renal. Nefrologia. 1993;13(5):493-9
Redón Más J, Abellán Alemán J, Aranda Lara P, De la Figuera von Wichmann M, Luque Otero M, Rodicio Díaz JL, et al. Antihypertensive activity of verapamil: impact of dietary sodium. The VERSAL Study Group. J Hypertens. 1993 Jun;11(6):665-71 [PubMed]
Robles RG, Villa E, Andrés A, Martínez J, Ruilope LM, Sancho JM. Natriuretic effects of dopamine agonist drugs in models of reduced renal mass. J Cardiovasc Pharmacol. 1993;22 Suppl 2:S88-92 [PubMed]
Robles RG, Villa E, Rábano A, Álvarez E, Martínez J, Ruilope LM, et al. Effect of cicaprost on the progression of diabetic nephropathy in uninephrectomized streptozotocin-induced diabetic rats. J Hypertens Suppl. 1993 Dec;11(5):S208-9 [PubMed]
Rodicio JL, Morales JM, Alcázar JM, Ruilope LM. Calcium antagonists and renal protection. J Hypertens Suppl. 1993;11(1):S49-53.
Rodicio JL, Morales JM, Ruilope LM. Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity. J Hypertens Suppl. 1993;11(6):S21-5.
Rodicio JL, Ruilope LM. Angiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertension. Clin Exp Hypertens. 1993;15(6):1277-89.
Ruilope LM. Kidney and aetiology, pathology and management of essential hypertension. J Hum Hypertens. 1993;7(Suppl 1):S37-S41
Ruilope LM. The course of chronic renal failure and therapeutic intervention: Clinical studies. Cardiovascular Risk Factors. 1993;3(3):181-7
Ruilope LM, Araque A, Lahera V, Suarez C. Antihypertensive effect of nitrendipine in the hypertensive patient with renal impairment. Ren Fail. 1993;15(3):359-63.
Ruilope LM, Campo C, Lahera V. The kidney and arterial hypertension. Drugs. 1993;46(Suppl 2):108-12.
Ruilope LM, Lahera V. Influence of salt intake on the antihypertensive effect of carvedilol. J Hypertens Suppl. 1993;11(4):S17-9.
Ruilope LM, Rodicio JL. Clinical relevance of proteinuria and microalbuminuria. Curr Opin Nephrol Hypertens. 1993;2(6):962-7
Ruilope LM, Suárez C. Microalbuminuria: factor predictivo de riesgo cardiovascular y renal. Rev Clin Esp. 1993 May;192(9):415-6 [PubMed]
Ruilope LM, Suárez C. La proteinuria como factor de riesgo cardiovascular y renal. Med Clin (Barc). 1993 Feb 27;100(8):299-301 [PubMed]
Sánchez R, Praga M, Rivas Salas JJ, Araque A, Mazuecos A, Andrés A, et al. Compressive myelopathy due to dialysis-associated amyloidosis. Nephron. 1993;65(3):463-5.
.
1994
Artículos
Andrés A, Mazuecos A, Morales JM, Praga M, Martínez MA, Usera G, et al. Renal allograft infarction is a cause of early kidney transplant loss in the cyclosporine A era. Transplant Proc. 1994;26(5):2544-5.
Aranda Arcas JL, Sánchez R, Guijarro C, Araque A, Pulido F, Praga M, et al. Efecto de la pravastatina en la hipercolesterolemia asociada a proteinuria. An Med Interna. 1994;11(11):523-7
Araque A, Alamo C, Fraile B, Díaz Gonzalez R, Praga M. Nephrotic syndrome after extracorporeal shock wave lithotripsy. Nephron. 1994;68(3):393 [PubMed]
Barrientos A, Portolés J, Herrero JA, Torralbo A, Prats D, Gutierrez-Millet V, et al. Glomerular hyperfiltration as a nonimmunologic mechanism of progression of chronic renal rejection. Transplantation. 1994 Mar 15;57(5):753-6 [PubMed]
Bond G, Dal Palú C, Hansson L, Magnani B, Mancia G, Neiss A, et al. The E.L.S.A. trial: protocol of a randomized trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension. J Cardiovasc Pharmacol. 1994;23 Suppl 5:S85-7 [PubMed]
Franco A, Olivares J, Grino JM, Moreno F, Oppenheimer J, Vilardell J, et al. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group. Transplant Proc. 1994 Oct;26(5):2522-4 [PubMed]
Hansson L, Vanzwieten P, Myers M, Reid J, Rodicio J, Menard J, et al. Methodological Aspects of the Trough-Peak Measurement – Discussion. J Hypertens. 1994;12:S27-8
Hernández Martínez E, Oliet A. Estudio cooperativo de nutrición en hemodiálisis I. Material y métodos. Nefrologia. 1994;14(Supl 2):31-5
Mazuecos A, Andrés A, Sánchez R, Araque A, Villena MV, De Prada I, et al. Enfermedad de wegener con inicio exclusivamente renal. Nefrologia. 1994;14(3):345-50
Morales JM, Muñoz MA, Campo C, Andrés A, Araque A, Álamo C, et al. Renal transplantation in older patients with doublé therapy with optional change to cyclosporine monotherapy: long-term results. Transplant Proc. 1994;26(5):2511-2
Morales JM, Rodríguez Paternina E, Araque A, Andrés A, Hernández E, Ruilope LM, et al Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study. Transplant Proc. 1994 Oct;26(5):2598-9 [PubMed]
Pablos JL, Gutiérrez Millet V, Gómez Reino JJ. Remission of lupus nephritis with cyclophosphamide and late relapses following therapy withdrawal. Scand J Rheumatol. 1994;23(3):142-4.
Rodicio JL. Clinical experience in the treatment of nondiabetic renal disease: Summary and concluding remarks. Kidney Int Suppl. 1994;45:S179-S180
Rosa C, Cisneros E, Alcázar JM, Praga M. Glomerulonefritis membranosa como primera manifestación de una sarcoidosis. Nefrologia. 1994;14(5):602-5
Ruilope LM. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension. Am J Hypertens. 1994;7(2):129-36. Erratum in: Am J Hypertens 1994 Apr;7(4 Pt 1):379.
Ruilope LM. How much does the kidney participate in the origin of primary hypertension? Blood Press. 1994;3(4):216-8.
Ruilope LM, Alcázar JM, Hernández E, Praga M, Lahera V, Rodicio JL. Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int Suppl. 1994;45:S171-3.
Ruilope LM, Campo C, Rodicio JL. Relationship between blood pressure and renal function. J Hypertens Suppl. 1994;12(8):S55-9.
Ruilope LM, Lahera V, Alcázar JM, Praga M, Campo C, Rodicio JL. Randomly allocated study of the effects of standard therapy versus ACE inhibition on micro-albuminuria in essential hypertension. J Hypertens Suppl. 1994;12(4):S59-63.
Ruilope LM, Lahera V, Araque A, Suárez C, Rodicio JL, Romero JC. Electrolyte excretion and sodium intake. Am J Med Sci. 1994;307(Suppl 1):S107-11.
Ruilope LM, Lahera V, Rodicio JL. Evaluation of the renal effects of calcium antagonists. J Cardiovasc Pharmacol. 1994;23(Suppl 5):S49-53.
Ruilope LM, Lahera V, Rodicio JL, Romero JC. Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension. 1994;23(1):3-9
Ruilope LM, Lahera V, Rodicio JL, Romero JC. Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens. 1994 Jun;12(6):625-31 [PubMed]
Suárez C, Ruilope LM. Modificación de la historia natural de la hipertensión arterial esencial mediante el tratamiento antihipertensivo. Med Clin (Barc). 1994;102(16):624-9 [PubMed]
.
1995
Artículos
Araque A, Sánchez R, Álamo C, Torres N, Praga M. Evolution of immunoglobulin A nephropathy into Henoch-Schönlein purpura in an adult patient. Am J Kidney Dis. 1995;25(2):340-2
Barril G, Traver JA. Prevalence of hepatitis C virus in dialysis patients in Spain. Spanish Multicentre Study Group. Nephrol Dial Transplant. 1995;10 Suppl 6:78-80 [PubMed]
Corell A, Morales JM, Mandroño A, Muñoz MA, Andrés A, Fuertes A, et al. Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection. Lancet. 1995 Dec 2;346(8988):1497-8 [PubMed]
García Bravo M, Aguado JM, Morales JM, Hayek M, Díaz González R, Gimeno Fernández C, et al. Corynebacterium urealyticum en pacientes con transplante renal. Med Clin (Barc). 1995;104(15):561-4
Grinyo J, Groth C, Pichlmayr R, Sadek SA, Vanrenterghem Y, Bherend M, et al. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet. 1995 May 27;345(8961):1321-5 [PubMed]
Hernández E, Morales JM, Andrés A, Ortuño B, Praga M, Alcázar JM, et al. Usefulness and safety of treatment with captopril in posttransplant erythrocytosis. Transplant Proc. 1995;27(4):2239-41
Hernandez E, Morales JM, Andrés A, Praga M, Mazuecos A, Cisneros C, et al. Pulmonary hemorrhage in renal transplant recipients. Nephron. 1995;69(2):199-200 [PubMed]
Hernández E, Praga M, Alcázar JM. Accidental hypothermia. N Engl J Med. 1995 Apr 13;332(15):1034; author reply 1035 [PubMed]
Lloveras J, Arias M, Andrés A, Puig JM, Escallada R, Morales JM, et al. Five-year follow-up of 250 recipients of cadaveric kidney allografts from donors older than 55 years of age. Transplant Proc. 1995 Feb;27(1):981-3 [PubMed]. Erratum in: Transplant Proc 1995 Apr;27(2):1916
Mazuecos A, Núñez V, Gómez B, Manrique A, Andrés A, Hidalgo E, et al. Usefulness of isotopic renography with captopril in the diagnosis of transplant renal artery stenosis. Transplant Proc. 1995;27(4):2242-3
Melero M, Rodríguez M, Araque A, Álamo C, Andrés A, Praga M. Idiopathic dialysis ascites in the nineties: resolution after renal transplantation. Am J Kidney Dis. 1995;26(4):668-70
Morales JM. Hepatitis C and renal transplantation: outcome of patients. Nephrol Dial Transplant. 1995;10(Suppl 6):125-8
Morales JM, Campistol JM, Bruguera M, Andrés A, Oppenheimer F, Rodicio JL. HCV and organ transplantation. Lancet. 1995 May 6;345(8958):1174-5 [PubMed]
Morales JM, Campistol JM, Castellano G, Andrés A, Colina F, Fuertes A, Ercilla G, et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int. 1995;47(1):236-40
Morales JM, Domingo MJ, Fuertes A. Hepatitis C virus in renal transplant patients. Am J Kidney Dis. 1995 Oct;26(4):693 [PubMed]
Morales JM, Muñoz MA, Fernández Zataraín G, García Cantón C, García Rubiales MA, Andrés A, et al. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients. Nephrol Dial Transplant. 1995;10(6):882-3
Muñoz García R, Maeso R, Rodrigo E, Navarro J, Ruilope LM, Casal MC, et al. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide. J Hypertens. 1995 Dec;13(12 Pt 2):1779-84 [PubMed]
Pérez Carreras M, Castellano G, Cisneros E, Morales J. Intrahepatic percutaneous portosystemic shunt – new alternative treatment in portal-hypertension. Nefrologia. 1995;15(3):299-300
Praga M. Case 12-1995: acute postinfectious glomerulonephritis. N Engl J Med. 1995 Aug 24;333(8):524-5 [PubMed]
Praga M, Hernández E, Andrés A, León M, Ruilope LM, Rodicio JL. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70(1):35-41.
Praga M, Vara J, González Parra E, Andrés A, Álamo C, Araque A, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Kidney Int. 1995;47(5):1419-25
Puig JG, Ruilope LM, Ortega R. Antihypertensive treatment efficacy in type II diabetes mellitus. Dissociation between casual and 24-hour ambulatory blood pressure. Spanish Multicenter Study Group. Hypertension. 1995 Dec;26(6 Pt 2):1093-9 [PubMed]
Rodicio JL, Campo C, Ruilope LM. Renal effects of calcium antagonists. Nephrol Dial Transplant. 1995 Oct;10 Suppl 9:17-22 [PubMed]
Rodicio JL, Ruilope LM. Assessing renal effects and renal protection. J Hypertens Suppl. 1995;13(4):S19-25.
Ruilope LM. Effects of angiotensin converting enzyme inhibitors on the progression of diabetic nephropathy. J Hypertens Suppl. 1995;13(2):S91-3.
Ruilope LM. The hidden truth: what do the clinical trials really tell us about BP control? J Hum Hypertens. 1995;9(Suppl 2):S3-7
Ruilope LM, Suárez C. Las asociaciones de fármacos: alternativa en el tratamiento de la hipertensión arterial. Med Clin (Barc). 1995;104(16):620-1 [PubMed]
Suárez C, Ruilope LM. Papel de los diuréticos en el tratamiento de la hipertensión arterial. Med Clin (Barc). 1995;104(10):373-4 [PubMed]
.
1996
Artículos
Bornstein B, Arenas J, Morales JM, Praga M, Rodicio JL, Martinez A, Valdivieso L. Cyclosporine nephrotoxicity and rejection crisis: diagnosis by urinary enzyme excretion. Nephron. 1996;72(3):402-6.
Campo C, Lahera V, García Robles R, Cachofeiro V, Alcázar JM, Andrés A, et al. Aging abolishes the renal response to L-arginine infusión in essential hypertension. Kidney Int Suppl. 1996;55:S126-8.
García Bravo M, Aguado JM, Morales JM, Noriega AR. Influence of external factors in resistance of Corynebacterium urealyticum to antimicrobial agents. Antimicrob Agents Chemother. 1996;40(2):497-9.
Hernández E, Praga M, Álamo C, Araque A, Morales JM, Alcázar JM, et al. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis. Nephron. 1996;72(2):145-9
León JB, Rodríguez J, Díaz J. Multiple sclerosis. Med Clin. 1996;106(20):800
Liano F, Pascual J, Gámez C, Gallego A, Bajo MA, Sicilia LS, et al. Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Kidney Int. 1996;50(3):811-8
Maeso R, Navarro Cid J, Muñoz García R, Rodrigo E, Ruilope LM, Lahera V, et al. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats – Role of nitric oxide and angiotensin II type 2 receptors. Hypertension. 1996;28(6):967-72
Mazuecos A, Araque A, Sánchez R, Martínez MA, Güesmes A, Rivero M, et al. Systemic amyloidosis secondary to pyonephrosis. Resolution after nephrectomy. Nephrol Dial Transplant. 1996;11(5):875-8
Morales JM. Drug-induced hepatotoxicity. N Engl J Med. 1996;334(13):864
Morales JM. Management and prevention of acute renal failure in solid organ transplantation. Ren Fail. 1996;18(3):481-8
Morales JM, Muñoz MA, Fernández G, Zatarain. Acute renal failure associated with foscarnet therapy – Reply. Nephrol Dial Transplant. 1996;11(1):221
Morales JM, Rodicio JL. Should hepatitis C positive donors be accepted for renal transplantation? Curr Opin Nephrol Hypertens. 1996;5(3):199-201
Rodicio JL. Can the kidney prevent cardiovascular diseases? Clin Exp Hypertens. 1996;18(3-4):501-11.
Rodicio JL. Does antihypertensive therapy protect the kidney in essential hypertension? J Hypertens Suppl. 1996;14(2):S69-75; discussion S75-6.
Rodicio JL. Renal effects of calcium antagonists with special reference to manidipine hydrochloride. Blood Press Suppl. 1996;5:10-5
Ruilope LM. Arterial hypertension and vascular medicine. Clin Sci. 1996;90(3):159-60
Ruilope LM, Campo C, RodriguezArtalejo F, Lahera V, GarciaRobles R, Rodicio JL. Blood pressure and renal function: Therapeutic implications. J Hypertens. 1996;14(11):1259-63
Ruilope LM, Hansson L, Zanchetti A. Renal aspects of the hypertension optimal treatment (HOT) study. J Nephrol. 1996;9(3):147-151
Ruilope LM, Rodicio JL. Hypertension, atherosclerosis and microalbuminuria in ELSA. European Lacidipine Study of Atherosclerosis. Blood Press Suppl. 1996;4:48-52.
Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients. Blood Press. 1996;5(1):32-40
Sánchez Fructuoso AI, Torralbo A, Arroyo M, Luque M, Ruilope LM, Santos JL, et al. Occult lead intoxication as a cause of hypertension and renal failure. Nephrol Dial Transplant. 1996;11(9):1775-80
.
1997
Artículos
Alcázar JM, Caramelo CA, Alegre ER, Abad J. Ischaemic renal injury. Curr Opin Nephrol Hypertens. 1997;6(2):157-65.
Andrés A, Morales JM, Praga M, Campo C, Lahera V, García Robles R, et al. L-arginine reverses the antinatriuretic effect of cyclosporin in renal transplant patients. Nephrol Dial Transplant. 1997;12(7):1437-40
Brown MJ, Castaigne A, De Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. INSIGHT – study rationale and design. Int J Clin Pract Suppl. 1997;(92):39-40
Campo C, García Vallejo O, Barrios V, Lahera V, Manero M, Esteban E, et al. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure. J Hypertens. 1997;15(12 Pt 2):1803-8
Domínguez Auñon JD, Postigo Llorente C, Llamas Martin R, Zarco Olivo C, Lopez Rios F, Guerra Tapia A, et al. Lichen myxoedematosus associated with human immunodeficiency virus infection–report of two cases and review of the literature. Clin Exp Dermatol. 1997 Nov;22(6):265-8 [PubMed]
García Bravo M, Aguado JM, Morales JM, Rodríguez Noriega A. Efficacy of a selective and differential medium for isolating corynebacterium urealyticum from urine specimens. Clin Microbiol Infect. 1997;3(5):555-8
Hernández E, Toledo T, Álamo C, Mon C, Rodicio JL, Praga M. Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition. Am J Kidney Dis. 1997;30(3):397-403
Lahera V, Navarro Cid J, Cachofeiro V, García Estañ J, Ruilope LM. Nitric oxide, the kidney, and hypertension. Am J Hypertens. 1997 Jan;10(1):129-40 [PubMed]
Maeso R, Rodrigo E, Muñoz García R, Navarro Cid J, Ruilope LM, Lahera V, et al. Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: role of nitric oxide. J Hypertens. 1997 Dec;15(12 Pt 2):1677-84 [PubMed]
Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection – A report of the European Tacrolimus Multicenter Renal Study Group. Transplantation. 1997;64(3):436-43
Morales E, Alegre R,. Herrero JC, Morales JM, Ortuño T, Praga M. Hepatitis-C-virus-associated cryoglobulinaemic mebranoproliferative glomerulonephritis in patients infected by HIV. Nephrol Dial Transplant. 1997;12(9):1980-1984
Morales JM, Campistol JM, Andrés A, Rodicio JL. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation. Curr Opin Nephrol Hypertens. 1997;6(6):511-5.
Morales JM, Martinez MA, Muñoz de Bustillo E, Muñoz MA, Gota R, Usera G. Recurrent type III membranoproliferative glomerulonephritis after kidney transplantation. Transplantation. 1997 Apr 27;63(8):1186-8 [PubMed]
Morales JM, Pascual Capdevila J, Campistol JM, Fernández Zatarain G, Muñoz MA, Andrés A, et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation. 1997;63(11):1634-9
Praga M. Progresión de la insuficiencia renal crónica en el paciente geriátrico. Nefrologia. 1997;17(Supl 3):68-72
Praga M, Paz Artal E, Hernández E, Segura J, Moreno MA, Morales JM, et al. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis. Nephrol Dial Transplant. 1997;12(12):2576-9
Rodicio JL. Modern combination therapy: the way forward in the management of hypertensive patients. Proceedings of an international symposium. Barcelona, Spain, 1-2 November 1996. J Hypertens Suppl. 1997 Mar;15(2):S1 [PubMed]
Rodrigo E, Maeso R, Muñoz García R, Navarro Cid J, Ruilope LM, Cachofeiro V, et al. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril. J Hypertens. 1997 Jun;15(6):613-8 [PubMed]
Ruilope LM. Clinical nephrology. Curr Opin Nephrol Hypertens. 1997 Mar 1;6(2):119 [PubMed]
Ruilope L. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist. J Hypertens Suppl. 1997;15(7):S15-20
Ruilope LM. The kidney and cardiovascular risk. Nephrol Dial Transplant. 1997 Feb;12(2):243-5 [PubMed]
Ruilope LM. Microalbuminuria as risk in essential hypertension. Nephrol Dial Transplant. 1997;12 Suppl 2:2-5
Ruilope LM. Microalbuminuria in non-diabetic hypertensive patients: Incidence, prevalence and value in predicting clinical outcome. Int J Clin Pract Suppl. 1997;(92):46-51
Ruilope LM. Prevalence of renal disease in elderly hypertensive patients with cardiovascular problems. Coron Artery Dis. 1997;8(8-9):483-8.
Ruilope LM. Relationship between cardiac hypertrophy and microalbuminuria. Adv Exp Med Biol. 1997;432:135-43.
Ruilope LM. Renal implications of arterial hypertension. Curr Opin Nephrol Hypertens. 1997;6(2):152-6.
Ruilope LM. Renoprotection and renin-angiotensin system blockade in diabetes mellitus. Am J Hypertens. 1997;10(12 Pt 2):325S-331S.
Ruilope LM, García Robles R. How far should blood pressure be reduced in diabetic hypertensive patients? J Hypertens Suppl. 1997;15(2):S63-5
Ruilope LM, Hansson L, Zanchetti A. What have we learned from the HOT (Hypertension Optimal Treatment) study? Nephrol Dial Transplant. 1997 Oct;12(10):2047-8 [PubMed]
Ruilope LM, Suárez C. How should we treat hypertensive women with cardiac and renal impairment? Am J Hypertens. 1997;10(10 Pt 2):242S-246S
Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter’s syndrome type III. Nat Genet. 1997 Oct;17(2):171-8 [PubMed]
Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997 Sep 13;350(9080):757-64 [PubMed]
Villa E, Rábano A, Cazes M, Cloarec A, Ruilope LM, García Robles R. Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy. Am J Hypertens. 1997 Mar;10(3):275-81 [PubMed]
.
1998
Artículos
Alcázar de la Osa JM, Fernández Valenzuela V, Rodríguez de la Calle J, Vidal Barraquer Mayol F. Consenso sobre patología aneurismática y obstructiva de la arteria renal. Angiología (1998);50:255-84
Alcázar de la Osa JM, Fernández Valenzuela V, Rodríguez de la Calle J, Vidal Barraquer Mayol F. Patología aneurismática de la arteria renal. Angiologia. 1998;50(6):257-68
Alcázar de la Osa JM, Fernández Valenzuela V, Rodríguez de la Calle J, Vidal Barraquer Mayol F. Patología obstructiva de la arteria renal. Angiologia. 1998;50(6):269-84
Andrés A, Herrero JC, Praga M, Segura J, Rodicio JL, Morales JM. Trasplante renal con donantes de edad avanzada. Nefrologia. 1998;18(Supl 5):50-8
Fernández Miranda C, De la Calle A, Morales JM, Guijarro C, Aranda JL, Gómez Sanz R, et al. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study. Clin Transplant. 1998;12(2):136-41. Erratum in: Clin Transplant 1998;12(5):487.
González Albarrán O, García Robles R, Ruilope LM. Therapeutic implications and new perspectives for essential hypertension and renal damage. Kidney Int Suppl. 1998;68:S46-50
González Albarrán O, Ruilope LM, Villa E, García Robles R. Salt sensitivity: concept and pathogenesis. Diabetes Res Clin Pract. 1998 Apr;39 Suppl:S15-S26 [PubMed]
Maeso R, Rodrigo E, Muñoz García R, Navarro Cid J, Ruilope LM, Cachofeiro V, et al. Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats. J Hypertens. 1998 May;16(5):665-72 [PubMed]
Maeso R, Rodrigo E, Muño García R, Navarro Cid J, Ruilope LM, Cachofeiro V, et al. Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR. Kidney Int. 1998;54:S30–S35
Manzanares C, Moreno M, Castellanos F, Cubas A, Herrero JC, Morales Ruiz E, et al. Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. Transplant Proc. 1998;30(4):1264-5
Morales JM. Renal transplantation in patients positive for hepatitis B or C (pro). Transplant Proc. 1998 Aug;30(5):2064-9 [PubMed]
Morales JM, Andrés A, Pallardo L, Capdevila L, Campistol JM, Vernet JMG, et al. Consensus document on suboptimal donors. Nefrologia. 1998;18:32-46
Morales JM, Campistol JM, Andrés A, Rodicio JL. Hepatitis C virus and renal transplantation. Curr Opin Nephrol Hypertens. 1998;7(2):177-83
Morales JM, Domingo MJ, Losada P, Fuertes A, Andrés A, Castellano G, et al. Hepatopatía por virus C en pacientes con transplante renal. Nefrologia. 1998;18(Supl 1):60-9
Muñoz de Bustillo E, Ibarrola C, Andrés A, Colina F, Morales JM. Hepatitis-B-virus-related fibrosing cholestatic hepatitis after renal transplantation with acute graft failure following interferon-alpha therapy. Nephrol Dial Transplant. 1998;13(6):1574-6.
Muñoz de Bustillo E, Ibarrola C, Colina F, Castellano G, Fuertes A, Andrés A, et al. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients. J Am Soc Nephrol. 1998;9(6):1109-13
Praga M. New insights into familial microhematuria. Curr Opin Nephrol Hypertens. 1999;8(2):173-7
Praga M. Tratamiento de las glomerulonefritis crónicas. Nefrologia. 1998;18(Supl 6):52-61
Praga M, Martínez MA, Andrés A, Alegre R, Vara J, Morales E, et al. Association of thin basement membrane nephropathy with hypercalciuria, hyperuricosuria and nephrolithiasis. Kidney Int. 1998;54(3):915-20
Praga M, Morales E, Herrero JC, Revilla Y, Bell I, González RD. Disminución de la masa renal funcionante y proteinuria. Nefrologia. 1998;18(Supl 1):17-22
Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998 Feb;31(2):712-8 [PubMed]
Rodicio JL. Brief history of the Spanish Society and League Against Hypertension. Am J Kidney Dis. 1998;32(1):xliii-xlv.
Rodicio JL, Campo C, Ruilope LM. Microalbuminuria in essential hypertension. Kidney Int Suppl. 1998;68:S51-4
Rodicio JL, Neumayer HH, Vanrenterghem YSC, Uleri S, Costa B, Ravinetto R. A study to assess the efficacy of lacidipine to prevent the deterioration of renal function in renal transplant patients receiving cyclosporine A as part of their immunosuppressive protocol. J Hypertens. 1998;16:S41–S43
Ruilope LM, Campo C, Rodicio JL. Blood pressure control, proteinuria and renal outcome in chronic renal failure. Curr Opin Nephrol Hypertens. 1998 Mar;7(2):145-8 [PubMed]
Ruilope LM, Coca A. The role of combination therapy in the treatment of hypertension. Blood Press Suppl. 1998;1:22-6.
Ruilope LM, García Robles R. How to treat the diabetic hypertensive individual appropriately. J Hypertens Suppl. 1998;16(1):S91-S93
Ruilope L, Zanchetti A. Angiotensin II blockade: blood pressure control and end-organ protection as combined goals – Proceedings of the IFECC-V Symposium – 5 February, 1998 – Monte Carlo, Monaco – Introduction. J Hypertens. 1998;16:S1–S2
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998 Jul;16(7):949-61 [PubMed]
.
1999
Artículos
Andrés A, Herrero JC, Morales E, Praga M, Vázquez S, Vereda M, Cebrián P, Rodicio JL, Morales JM, Aguirre F, Diaz R, Polo G, Leiva O. The double or single renal graft depending on the percentage of glomerulosclerosis in the preimplant biopsy reduces the number of discarded kidneys from donors older than 60 years. Transplant Proc. 1999;31(6):2285-6.
Andrés A, Sánchez Casado M, Cebrián P, Vereda M, Vázquez S, Morales E, Ramos A, Escudero L, Montejo JC, Montero A, Alted E. Very old patients with spontaneous cerebral hemorrhage are an important group of potential organ donors. Transplant Proc. 1999;31(6):2593-4
Behrend M, Grinyo J, Vanrenterghem Y, Rodicio J, Albrechtsen D, Sadek S, et al. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation. 1999;68(3):391-6
Bello E, Caramelo C, López MD, Soldevilla MJ, González Pacheco FR, Rovira A, et al. Induction of microalbuminuria by l-arginine infusion in healthy individuals: an insight into the mechanisms of proteinuria. Am J Kidney Dis. 1999 Jun;33(6):1018-25 [PubMed]
Campistol JM, Mazuecos A, Segura J, Osuna A, Herrero JC, Andrés A, Oppenheimer F, Gómez de la Camara A, Martínez MA, Morales JM. Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study. Transplant Proc. 1999;31(6):2267-9.
Caramelo C, Bello E, Ruiz E, Rovira A, Gazapo RM, Alcázar JM, Martell N, Ruilope LM, Casado S, Fernández Guerrero M. Hyperkalemia in patients infected with the human immunodeficiency virus: involvement of a systemic mechanism. Kidney Int. 1999;56(1):198-205.
Cubas A, Herrero JC, Morales E, Carreño A, Domínguez Gil B, Cirujeda A, Praga M, Ortuño T, Hernández E, Delgado M, Andrés A, Morales JM. The early impact of mycophenolate mofetil in combination with steroids and cyclosporine Neoral after renal transplantation: a six-month analysis. Transplant Proc. 1999;31(6):2265-6
De las Heras N, Aragoncillo P, Maeso R, Vázquez Pérez S, Navarro Cid J, DeGasparo M, et al. AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits. Hypertension. 1999 Oct;34(4 Pt 2):969-75 [PubMed]
Delgado J, Muñoz de Bustillo E, Ibarrola C, Colina F, Morales JM, Rodríguez E, Aguado JM, Fuertes A, Gómez MA. Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor? J Heart Lung Transplant. 1999;18(6):607-10
Díez J, Madias NE, Egido J, Rodicio JL, Lamas S, Zucchelli P, et al. Insulin-like growth factor I in essential hypertension. Kidney Int. 1999;55(2):744-59
Domínguez Gil B, Herrero JC, Carreño A, Morales E, Andrés A, Aguado JM, Díaz González R, Benito A, Morales JM. Ureteral stenosis secondary to encrustation by urea-splitting Corynebacterium urealyticum in a kidney transplant patient. Nephrol Dial Transplant. 1999;14(4):977-8.
Fernández Aparicio T, Miñana López B, Polo Villar G, Díaz González R, Fraile Gómez B, Aguirre Benitez F, Morales Cerdán JM, Leiva Galvis O. Influencia de la trasplantectomía del primer injerto en la evolución del retrasplante renal de cadáver. Actas Urol Esp. 1999;23(10):864-72
Groth CG, Bäckman L, Morales JM, Calne R, Kreis H, Lang P, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation. 1999 Apr 15;67(7):1036-42 [PubMed]
Herrero JC, Andrés A, Praga M, Morales E, Domínguez Gil B, Carreño A, Hernández E, Morales JM. Long-term results of renal transplants from donors older than 60 years. Transplant Proc. 1999;31(6):2281-2.
Herrero JC, Morales E, Domínguez Gil B, Carreño A, Cubas A, Andrés A, Praga M, Ortuño T, Hernández E, Rodicio JL, Morales JM. Mycophenolate mofetil, cyclosporine, and steroids after renal transplantation: five-year results at a single center. Transplant Proc. 1999;31(6):2263-4
Maeso R, Navarro Cid J, Rodrigo E, Ruilope LM, Lahera V, Cachofeiro V. Differential effects of losartan and doxazosin on vascular function in senescent spontaneously hypertensive rats. Am J Hypertens. 1999 Nov;12(11 Pt 1):1105-8 [PubMed]
Maeso R, Navarro Cid J, Rodrigo E, Ruilope LM, Cachofeiro V, Lahera V. Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME. J Hypertens. 1999 Feb;17(2):221-7 [PubMed]
Morales JM. Hepatitis C virus infection and renal transplantation. Transplant Proc. 1999;31(6):2221-4.
Morales E, Andrés A, Herrero JC, Domínguez Gil B, Carreño A, Morales JM, Hernández E, Ortuño T, Praga M. Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection. Transplant Proc. 1999;31(6):2248-9.
Morales JM, Andrés A, Morales E, Herrero JC, Cubas A, Praga M, Hernández E, Ortuño T, Domínguez Gil B, Carreño A, Delgado M, Manzanares C. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid. Transplant Proc. 1999;31(7A):75S-77S
Morales E, Hernández E. La enfermedad renal en la esclerosis sistémica. Rev Esp Reumatol. 1999;26(6):219-25
Morales E, Herrero JC, Domínguez Gil B, Carreño A, Usera G, Praga M. The unusual diabetic patient with advanced renal insufficiency on ACE inhibitors. What is the explanation for her persisting hypokalaemia? Nephrol Dial Transplant. 1999;14(5):1313-4.
Moreno M, Latorre A, Manzanares C, Morales E, Herrero JC, Domínguez Gil B, Carreño A, Cubas A, Delgado M, Andrés A, Morales JM. Clinical management of tacrolimus drug interactions in renal transplant patients. Transplant Proc. 1999;31(6):2252-3
Morales JM, Morales E, Andrés A, Praga M. Glomerulonephritis associated with hepatitis C virus infection. Curr Opin Nephrol Hypertens. 1999;8(2):205-11
Praga M, Morales E, Herrero JC, Pérez Campos A, Domínguez Gil B, Alegre R, Vara J, Martínez MA. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis. 1999;33(1):52-8
Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens. 1999 Jul;17(7):869-72 [PubMed]
Ruilope LM. Cardiovascular and renal risks of calcium-channel blockers–news from the HOT study. Nephrol Dial Transplant. 1999 Feb;14(2):286-7 [PubMed]
Ruilope LM. Is it wise to combine an ACE inhibitor and an angiotensin receptor antagonist? Nephrol Dial Transplant. 1999;14(12):2855-6.
Ruilope LM. The kidney as part of the cardiovascular system. J Cardiovasc Pharmacol. 1999;33 Suppl 1:S7-10; discussion S41-S43
Ruilope LM, Barrios V, Segura J, Campo C. The kidney in heart failure: Role of angiotensin II. Curr Opin Nephrol Hypertens. 1999;8(2):153-6
Ruilope LM, De la Sierra A, Moreno E, Fernández R, Garrido J, De la Figuera M, Gómez de la Cámara A, Coca A, Luque Otero M. Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study. J Hypertens. 1999;17(12 Pt 2):1917-23.
Ruilope LM, Rodicio JL. Renal surrogates in essential hypertension. Clin Exp Hypertens. 1999;21(5-6):609-14
Sánchez V, Delgado JF, Blasco T, Dalmau R, Morales JM, Escribano P, Tello R, Hernández J, Velázquez T, Sotelo T, Gómez-Sánchez MA, Sáenz de la Calzada C. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy. Transplant Proc. 1999;31(6):2515-6
Simon DB, Lu Y, Choate KA, Velázquez H, Al-Sabban E, Praga M, et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption. Science. 1999 Jul 2;285(5424):103-6 [PubMed]
Suárez C, Cucala M, Coca A, Ruilope LM. Contribución española al estudio HOT (Hypertension Optimal Treatment). Resultados finales. Investigadores españoles del Estudio HOT. Med Clin (Barc). 1999 Oct 2;113(10):361-5 [PubMed]
Suárez C, Ruilope LM. Una nueva guía de la Organización Mundial de la Salud y la Sociedad Internacional de Hipertensión para el manejo de la hipertensión arterial: Hacia una guía común. Rev Esp Cardiol. 1999;52(6):381-2
.
2000
Artículos
Alcázar J, Rodicio J. Hypertension and ischemic nephropathy. Curr Hypertens Rep. 2000;2(4):343-4.
Alcázar JM, Rodicio JL. Ischemic nephropathy: clinical characteristics and treatment. Am J Kidney Dis. 2000;36(5):883-93.
Andrés A, Morales JM, Herrero JC, Praga M, Morales E, Hernández E, Ortuño T, Rodício JL, Martínez MA, Usera G, Díaz R, Polo G, Aguirre F, Leiva O. Double versus single renal allografts from aged donors. Transplantation. 2000;69(10):2060-6
Aragoncillo P, Maeso R, Vázquez Pérez S, Navarro Cid J, Ruilope LM, Díaz C, et al. The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits. Virchows Arch. 2000 Nov;437(5):545-54 [PubMed]
Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Palmer CR, Rosenthal T, et al. Influence of diabetes and type of hypertension on response to antihypertensive treatment. Hypertension. 2000 May;35(5):1038-42 [PubMed]
Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000 Jul 29;356(9227):366-72 [PubMed]. Erratum in: Lancet 2000 Aug 5;356(9228):514
Campistol JM, Esforzdo N, Barrera JM, Morales JM, Oppenheimer F. Hepatitis C virus-positive patients on the waiting list for transplantation: study, evaluation and treatment. Nephrol Dial Transplant. 2000;15 Suppl 8:68-70 [doi]
Campo C, Fernández G, González Esteban J, Segura J, Ruilope LM; ESPADA Study Group. Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA study. Blood Press. 2000;9(6):355-62.
Carreño A, Morales E, Domínguez Gil B, Herrero JC, Ortiz M, González E, Praga M. The patient with over 100 relapses of minimal change nephrotic syndrome: prolonged complete remission after chlorambucil treatment. Nephrol Dial Transplant. 2000;15(6):922-923
Cea Calvo L, Lozano F, Pombo M, Serrano A, Rodríguez E, Porto J, Pozuelo A, González C. Images in cardiovascular medicine. Uterine intravenous leiomyomatosis extending through the inferior vena cava into the right cardiac cavities. Circulation. 2000;101(5):581-3
Coca A, Ruilope LM. El bloqueo del sistema renina-angiotensina reduce la mortalidad y morbilidad cardiovascular atribuible a la hipertensión arterial en prevención primaria y secundaria. El final del camino? Med Clin (Barc). 2000 Jul 1;115(5):178-80 [PubMed]
De la Sierra A, Ruilope LM, Coca A, Luque Otero M. Relación entre el perfil de riesgo cardiovascular y la selección y utilización de los fármacos antihipertensivos. GEDEC (Grupo Español de Estudios Cardiovasculares). Med Clin (Barc). 2000;115(2):41-5 [doi]
Domínguez Gil B, Hernández E, Carreño A, González E, Ortiz M, Sierra MP, Rodicio JL, Praga M. Peculiaridades diagnósticas y evolutivas de la glomerulonefritis membranosa lípica. Nefrologia. 2000;20(6):523-31
Escribá A, Morales E, Albizúa E, Herrero JC, Ortuño T, Carreño A, et al. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica. Am J Kidney Dis. 2000;35(1):137-40
Escribano Subías P, López-Ríos F, Delgado Jiménez JF, Sotelo Rodríguez T, Aguado JM, Rodríguez Hernández E. Aneurisma micótico por Aspergillus en la línea de sutura aórtica tras el trasplante cardíaco. Rev Esp Cardiol. 2000;53(10):1403-5
Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102(10):1139-44 [doi]
Fernández Aparicio T, Miñana López B, Polo Villar G, Díaz González R, Fraile Gómez B, Aguirre Benites F, Morales Cerdán JM, Leiva Galvis O. Compatibilidad HLA y reexposicion antigenica. Influencia en la evolucion del retrasplante renal de cadáver. Arch Esp Urol. 2000;53(1):53-64.
Fernández Miranda C, De la Calle M, Larumbe S, Gómez Izquierdo T, Porres A, Gómez Gerique J, Enríquez de Salamanca R. Lipoprotein abnormalities in patients with asymptomatic acute porphyria. Clin Chim Acta. 2000;294(1-2):37-43.
Fernández Miranda C, Gómez P, Díaz Rubio P, Estenoz J, Carillo JL, Andrés A, et al. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. Clin Transplant. 2000;14(2):110-4 [doi]
Gomez Martin C, Solá C, Hornedo J, Perea S, Lumbreras C, Valentí V, Arcediano A, Rodríguez M, Salazar R, Cortés Funes H, Hidalgo M. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cáncer patients: results of a randomized clinical trial. J Clin Oncol. 2000;18(10):2126-34
González E, Rada MA, Lumbreras C, Ramos JT, Aguado JM. Seguridad de la anfotericina B liposomal en pacientes con elevado riesgo de nefrotoxicidad. Enferm Infecc Microbiol Clin. 2000;18(4):162-4
Grinyó JM, Morales JM. Inmunosupresión después de un trasplante renal [Immunosuppression after renal transplantation]. Nefrologia. 2000;20 Suppl 3:59-67 [PubMed]
Hernández G, Arriba L, Lucas M, De Andrés A. Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. J Periodontol. 2000;71(10):1630-6 [doi]
Jiménez JS, Martín I, De la Fuente L, Muñoz JL, Vaquero G, Ramírez M, Pérez C, De La Fuente P. Severe menorrhagia due to Glanzmann thrombasthenia treated with hydrothermal ablation. J Am Assoc Gynecol Laparosc. 2000;7(2):265-7
Kreis H, Cisterne JM, Land W, Wramner L, Squifflet JP, Abramowicz D, et al. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation. 2000;69(7):1252-60 [doi]
Maeso R, Aragoncillo P, Navarro Cid J, Ruilope LM, Diaz C, Hernández G, Lahera V, Cachofeiro V. Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits. Vasc Pharmacol. 2000;34(4):263-72
Morales JM, Campistol JM. Transplantation in the patient with hepatitis C. J Am Soc Nephrol. 2000;11(7):1343-53
Morales JM, Campistol JM, Andrés A, Domínguez Gil B, Esforzado N, Muñoz MA, Bruguera M, Oppenheimer F, Rodicio JL. Policies concerning the use of kidneys from donors infected with hepatitis C virus. Nephrol Dial Transplant. 2000;15(Suppl 8):71-3
Morales JM, Campistol JM, Andrés A, Herrero JC. Immunosuppression in older renal transplant patients. Drugs Aging. 2000;16(4):279-87
Praga M. Nefropatía por hiperfiltración. Nefrologia. 2000;20(4):311-35
Praga M, Alegre R, Hernández E, Morales E, Domínguez Gil B, Carreño A, Andrés A. Familial microscopic hematuria caused by hypercalciuria and hyperuricosuria. Am J Kidney Dis. 2000;35(1):141-5
Praga M, Hernández E, Herrero JC, Morales E, Revilla Y, Díaz González R, Rodicio JL. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000;58(5):2111-8
Praga Terente M. Anomalías del transporte paracelular y bases genéticas del síndrome de hipomagnesemia, hipercalciuria y nefrocalcinosis. Rev Esp Enferm Metab Oseas. 2000;9(4):135-6
Rodicio JL. Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients. J Cardiovasc Pharmacol. 2000;35(3 Suppl 1):S7-11 [doi]
Ruilope LM. Antihypertensive treatment of patients with diabetes and venal dysfunction: the INSIGHT trial. Eur Heart J Suppl. 2000;2:D):31-32
Ruilope LM. AT1-receptor blockers and ACE inhibitors: alternatives or partners? Int J Clin Pract Suppl. 2000;(111):20-4
Ruilope LM. Do we effectively lower blood pressure? J Cardiovasc Pharmacol. 2000;35 (Suppl 3):S3-6
Ruilope L. Improving Prognosis in Hypertension: Exploring the Benefits of Angiotensin II Type 1 Receptor Blockade. Blood Press. 2000;9(sup1):31-35 [PubMed]
Ruilope LM. New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease. J Renin Angiotensin Aldosterone Syst. 2000;1(2 Suppl):S29-31.
Ruilope L. RAS blockade: new possibilities in the treatment of complications of diabetes. Heart. 2000;84(Suppl 1):i32-4:discussion i50 [PubMed]
Ruilope LM, Aldigier JC, Ponticelli C, Oddou Stock P, Botteri F, Mann JF. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease. J Hypertens. 2000;18(1):89-95.
Ruilope LM, Barrios V, Volpe M. Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure. J Hypertens. 2000;18(11):1545-51
Suárez C, Ruilope LM. Hipertensión arterial: Cuanto más la conocemos peor la tratamos. Med Clin. 2000;114(10):379-80
Tena D, Abad JC, Lizasoaín M, Galán Dávila L, Sotelo T, Otero JR. Infiltrado pulmonar micronodular en un paciente con síndrome de inmunodeficiencia adquirida. Enferm Infecc Microbiol Clin. 2000;18(2):89-90
La Biblioteca recopila las publicaciones del H12O en... 1991-2000 